Brief: Enveric Biosciences Signs Non-Binding Term Sheets To Pursue The Exclusive Out-Licensing Of Three Classes Of Compounds
29/02/2024 12:41
Feb 29 (Reuters) - Enveric Biosciences Inc ENVB.O :
* ENVERIC BIOSCIENCES SIGNS NON-BINDING TERM SHEETS TO
PURSUE THE
EXCLUSIVE OUT-LICENSING OF THREE CLASSES OF COMPOUNDS
* ENVERIC BIOSCIENCES- CO COULD RECEIVE FUTURE
DEVELOPMENT,SALES
MILESTONE PAYMENTS,EXECUTION FEES FOR 3 LICENSES, WHICH COULD
ADD UP TO $200 MILLION
Source text for Eikon: ID:nBw3lMvgya
Further company coverage: ENVB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enveric Biosciences
See all newsBrief: Enveric Biosciences Announces Positive Results From IND-Enabling ADMET Studies
Enveric Biosciences Q2 net loss widens
AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
Brief: Enveric Biosciences Initiates Investigational New Drug (IND)-Enabling Genotoxicity Studies Of Lead Neuroplastogen Candidate EB-003
Brief: Enveric Biosciences Reports Positive Preclinical Results From Phototoxicity Analysis For Lead Neuroplastogen Candidate Eb-003